Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

24.28
Delayed Data
As of 4:00pm ET
 +0.23 / +0.96%
Today’s Change
10.85
Today|||52-Week Range
33.82
+28.13%
Year-to-Date

Today’s Trading

Previous close24.05
Today’s open24.23
Day’s range24.05 - 24.78
Volume7,925,286
Average volume (3 months)12,309,578
Market cap$20.7B
Data as of 4:00pm ET, 06/20/2018

Growth & Valuation

Earnings growth (last year)-23,426.50%
Earnings growth (this year)-35.03%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+2.60%
P/E ratioNM
Price/Sales0.85
Price/Book1.51

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd+5.15+3.12%
TYMETyme Technologies In...-0.17-4.57%
OASMOasmia Pharmaceutica...+0.11+8.46%
Data as of 4:00pm ET, 06/20/2018

Financials

Next reporting dateAugust 2, 2018
EPS forecast (this quarter)$0.62
Annual revenue (last year)$22.5B
Annual profit (last year)-$16.4B
Net profit margin-72.66%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Kåre Schultz
Executive Vice President-
Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Hamerkaz

Forecasts